PHARMA CONSULTING SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Key data
Status
ActiveKRS number
0000329066REGON
32064554500000NIP/VAT code
8522553110VAT registration date
27/05/2009VAT status
ActiveBankruptcy proceedings
No proceedingsPHARMA CONSULTING SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Contacts
Registered address
UL. LUDWIKA WARYŃSKIEGO 4A, 71-316, SZCZECIN, POLSKASee on map
Website
-
10/07/202527/06/202406/07/202329/08/202214/10/202102/09/202002/09/202024/07/201924/07/201929/12/201629/12/201629/12/201629/12/201629/12/201629/12/201629/12/2016Incorporation date
07/05/2009Share capital
179,000.00 PLNPrimary activity
Agents involved in the sale of machinery, industrial equipment, ships and aircraftRepresentatives
1Representatives rights
DO SKŁADANIA OŚWIADCZEŃ WOLI, REPREZENTOWANIA SPÓŁKI I ZACIĄGANIA ZOBOWIĄZAŃ WYMAGANE JEST WSPÓŁDZIAŁANIE DWÓCH CZŁONKÓW ZARZĄDU LUB CZŁONKA ZARZĄDU I PROKURENTA (REPREZENTACJA ŁĄCZNA).Representatives
Business linkages
Premium users: 1.00 credit
Financial report (Okredo)
Premium users: 1.00 credit
People
Representatives
Person  | Title |
|---|---|
J**** L******** | Chairman of the management board |
Persons with Significant Control
Persons with Significant Control
This information is available in our reports and to subscription users.Financial ratios
Net Profit (zł)
377,570Net Profit (zł)
377,570Financial report (Okredo)
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (zł) |
| Profit before tax (zł) |
| Net Profit (zł) |
Working capital requirement (%) |
| Liquidity ratio |
| Net profitability (%) |
| Equity (zł) |
| Current liabilities (zł) |
| Non current liabilities (zł) |
| Non-current Assets (zł) |
| 2021 |
|---|
| 2,239,011 |
| -347,797 |
| -347,797 |
| 0.03 |
| 1.20 |
| -15.53 |
| 66,901 |
| 328,387 |
| 0 |
| 0 |
| 2022 |
|---|
| 3,010,755 |
| 414,729 |
| 414,729 |
| 0.16 |
| 2.65 |
| 13.77 |
| 481,630 |
| 291,373 |
| 0 |
| 0 |
| 2023 |
|---|
| 3,217,169 |
| 380,515 |
| 377,570 |
| 0.19 |
| 2.20 |
| 11.74 |
| 625,637 |
| 523,000 |
| 0 |
| 0 |
| 2023 |
|---|
| 3,217,169 |
| 380,515 |
| 377,570 |
| 0.19 |
| 2.20 |
| 11.74 |
| 625,637 |
| 523,000 |
| 0 |
| 0 |
2023
Turnover (zł)
3,217,169 zł
7 % *
Profit before tax (zł)
380,515 zł
-8 % *
Net Profit (zł)
377,570 zł-9 % *
Working capital requirement (%)
0.19 
18.75 % *
Liquidity ratio
2.20 -16.98 % *
Net profitability (%)
11.74 %-14.74 % *
Equity (zł)
625,637 zł30 % *
Current liabilities (zł)
523,000 zł80 % *
Non current liabilities (zł)
0 zł
- *
Non-current Assets (zł)
0 zł- *
Credit history
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Creditor/Data source | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Documents
PHARMA CONSULTING SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ Documents
Date | Description |
|---|---|
10/07/2025 | OD 01.01.2024 DO 31.12.2024 |
27/06/2024 | OD 01.01.2023 DO 31.12.2023 |
06/07/2023 | OD 01.01.2022 DO 31.12.2022 |
29/08/2022 | OD 01.01.2021 DO 31.12.2021 |
14/10/2021 | OD 01.01.2020 DO 31.12.2020 |